Medical News

RSS

Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign

While Florida has the second highest cancer burden in the nation, the state has only one National Cancer Institute. Successfully applying for NCI designation must include a commitment for additional funding from the state. The Sylvester Comprehensive Cancer Center is launching “We Tackle Cancer” bringing attention to the critical need for a second NCI.

16 Mar 2010

NKF: Certain ethnic minorities are at higher risk for developing CKD

Certain ethnic minorities, including African Americans and Hispanics, are at a higher risk than the general population for developing potentially life-threatening chronic kidney disease (CKD), which has been linked to higher rates of diabetes and high blood pressure, according to the National Kidney Foundation.

16 Mar 2010

Unani.ca consumer-minded PEHR now available in Canadian marketplace

The McGill University Health Centre announced today that anyone with an Internet access and a desire to manage his or her health and well-being can now subscribe to Unani.ca. Co-developed with Quebec-owned Medical.MD, Unani.ca is the first consumer-minded personal electronic health record (PEHR) in the Canadian marketplace that combines the expertise of a world-class academic health centre with that of award-winning information-technology developers.

16 Mar 2010

PERSEUS clinical program comparing TAXUS Element Stent to prior-generation stents: 12-month results

Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R) Express(TM) Paclitaxel-Eluting Stent System.

16 Mar 2010

Study offers new possibilities for breast and other cancer therapies

Conventional biological wisdom holds that living cells interact with their environment through an elaborate network of chemical signals. As a result many therapies for the treatment of cancer and other diseases in which cell behavior goes awry focus on drugs that block or disrupt harmful chemical signals.

16 Mar 2010

Novo Nordisk awarded funds to support diabetes summer camps nationwide

Novo Nordisk Inc., a world leader in diabetes care, announced that it has awarded funds to support scholarships and capital improvements to diabetes summer camps at fifteen locations nationwide. In support of their dedication to meeting the needs of children with diabetes, the grants will help the camps provide financial assistance programs to campers and improve facilities for the campers' use.

From Novo Nordisk 16 Mar 2010

Drug-eluting stents offer new hope to patients with critical limb ischemia

In the United States, more than 100,000 amputations are performed each year on individuals with critical limb ischemia, the most severe form of peripheral arterial disease (PAD). The number one priority in treating these patients is to re-establish blood flow to avoid limb amputation.

16 Mar 2010

CT scan of heart's epicardial fat provides better prognosis compared to standard diagnostic techniques

Imaging epicardial adipose tissue, or the layer of fat around the heart, can provide extra information compared with standard diagnostic techniques such as coronary artery calcium scoring, according to research by cardiologists at Emory University School of Medicine.

16 Mar 2010

Global Nutrition Transition Conference: Physicians and nutrition scientists to discuss solutions for preventing obesity

Physicians and nutrition scientists from around the world gathered today in Orlando for the opening of the Global Nutrition Transition Conference in order to discuss emerging trends and grass roots solutions to the global obesity epidemic employing balanced nutrition and teaching healthy active lifestyles.

16 Mar 2010

Hitachi, NextDocs form partnership in document management solutions for pharmaceutical manufacturers

Hitachi, Ltd. and NextDocs Corporation today announced their newly formed partnership in document management solutions for pharmaceutical manufacturers.

16 Mar 2010

Roche Diagnostics named sole source supplier for Premier's blood glucose monitoring devices

Roche Diagnostics announced today that it has been awarded contracts for blood glucose monitoring and clinical chemistry/immunoassay lab analyzers from Premier Purchasing Partners, L.P., Inc., the group purchasing unit of Premier, Inc. Roche was also named the sole source supplier for blood glucose in Premier's exclusive ASCEND supply chain performance program.

From Roche Sequencing and Life Science 16 Mar 2010

AlloSource receives US patent for cleaning and disinfecting system

AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, has been awarded its first patent for a propriety tissue cleaning and disinfecting process called RICA.

16 Mar 2010

Uterine fibroids: Promising new minimally invasive treatment using high-energy ultrasound waves

There's a new interventional radiology tool showing promise in the treatment of uterine fibroids: magnetic resonance-guided focused ultrasound (MRgFUS), a minimally invasive treatment that uses high-energy ultrasound waves to generate heat at a specific point to destroy uterine fibroid tissue and relieve symptoms.

16 Mar 2010

Publix Pharmacies launches first phase of new diabetes management system

Today Publix Pharmacies launched the first phase of a new diabetes management system. The program is a multi-faceted program established to assist customers and associates living with diabetes in managing their medication, compliance, monitoring, education, nutrition and exercise.

16 Mar 2010

EXPLORE-Xa study: Betrixaban reduces CRNM bleeds compared to dose-adjusted warfarin

Portola Pharmaceuticals and Merck today announced the results of EXPLORE-Xa, a Phase 2 exploratory, dose finding study of betrixaban, an investigational oral direct Factor Xa inhibitor. Results showed that a once-daily dose of oral betrixaban, given to patients with non-valvular atrial fibrillation or atrial flutter and at least one risk factor for stroke, reduced the incidence of major and clinically relevant non-major (CRNM) bleeds compared to dose-adjusted warfarin.

16 Mar 2010

Researchers gain new understanding of cilial protein Arl13b in Joubert syndrome

Researchers in Ireland have gained new understanding of the role played by the cilial protein Arl13b in Joubert syndrome (JS), a rare disorder characterized by developmental delay, mental retardation, and low muscle tone, among other symptoms.

16 Mar 2010

Simcere Pharmaceutical Group report 15.5% sequential growth in fourth quarter revenues

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter and the fiscal year ended December 31, 2009.

16 Mar 2010

GE Healthcare introduces OSA diagnostic tool for inpatient cardiac patients

GE Healthcare today introduced MARS® Virtual Sleep Lab (VSL), the first device to provide a streamlined view of quantitative cardiac and sleep apnea analysis from any GE-monitored inpatient bed, helping enhance speed of diagnosis.

16 Mar 2010

RMG Networks acquires Pharmacy TV

RMG Networks announced today the acquisition of Pharmacy TV, a digital place-based video network deployed near the pharmacist counter in major grocery chains and pharmacy retailers. The network entertains and informs customers with wellness-related video content and relevant messages from the retailer and brand advertisers.

16 Mar 2010

Poniard Pharmaceuticals sells over 4.2M common shares to Commerce Court Small Cap Value Fund

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the sale of 4,229,000 of its common shares to Commerce Court Small Cap Value Fund, Ltd. for gross proceeds of approximately $6.3 million, or approximately $1.49 per share, under its existing committed equity financing facility with Commerce Court.

16 Mar 2010

Medical News

Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign

NKF: Certain ethnic minorities are at higher risk for developing CKD

Unani.ca consumer-minded PEHR now available in Canadian marketplace

PERSEUS clinical program comparing TAXUS Element Stent to prior-generation stents: 12-month results

Study offers new possibilities for breast and other cancer therapies

Novo Nordisk awarded funds to support diabetes summer camps nationwide

Drug-eluting stents offer new hope to patients with critical limb ischemia

CT scan of heart's epicardial fat provides better prognosis compared to standard diagnostic techniques

Global Nutrition Transition Conference: Physicians and nutrition scientists to discuss solutions for preventing obesity

Hitachi, NextDocs form partnership in document management solutions for pharmaceutical manufacturers

Roche Diagnostics named sole source supplier for Premier's blood glucose monitoring devices

AlloSource receives US patent for cleaning and disinfecting system

Uterine fibroids: Promising new minimally invasive treatment using high-energy ultrasound waves

Publix Pharmacies launches first phase of new diabetes management system

EXPLORE-Xa study: Betrixaban reduces CRNM bleeds compared to dose-adjusted warfarin

Researchers gain new understanding of cilial protein Arl13b in Joubert syndrome

Simcere Pharmaceutical Group report 15.5% sequential growth in fourth quarter revenues

GE Healthcare introduces OSA diagnostic tool for inpatient cardiac patients

RMG Networks acquires Pharmacy TV

Poniard Pharmaceuticals sells over 4.2M common shares to Commerce Court Small Cap Value Fund

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News